Low skeletal muscle mass are predictive factors of survival for advanced hepatocellular carcinoma

Low skeletal muscle mass are predictive factors of survival for advanced hepatocellular carcinoma

Bibliographic Details
Main Author:	Xiaofei Li
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	Journal of the Formosan Medical Association
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664620303971

Similar Items

Reply to letter to the editor: Low skeletal muscle mass are predictive factors of survival for advanced hepatocellular carcinoma
by: Chih-Horng Wu, et al.
Published: (2021-01-01)

Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma
by: Chih-Horng Wu, et al.
Published: (2021-01-01)

Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib
by: Kenji Imai, et al.
Published: (2019-08-01)

Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma
by: Shinji Itoh, et al.
Published: (2021-07-01)

Skeletal Muscle Depletion Predicts the Prognosis of Patients With Hepatocellular Carcinoma Treated With Radiotherapy
by: Joongyo Lee, et al.
Published: (2019-10-01)

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Hepatocellular Carcinoma Treated with Sorafenib
by: Kenji Imai, et al.
Published: (2015-04-01)

Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma
by: Issei Saeki, et al.
Published: (2021-05-01)

Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies
by: Takamasa Kobayashi, et al.
Published: (2018-07-01)

The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib.
by: Francesco Caputo, et al.
Published: (2020-01-01)

Predictive factors and survival for hospitalized patients with advanced hepatocellular carcinoma encountering serious adverse drug reactions
by: Shiang-Yih Ho, et al.
Published: (2012)

The Combination of Low Skeletal Muscle Mass and High Tumor Interleukin-6 Associates with Decreased Survival in Clear Cell Renal Cell Carcinoma
by: Joshua K. Kays, et al.
Published: (2020-06-01)

A Model Combining Skeletal Muscle Mass and a Hematological Biomarker to Predict Survival in Patients With Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy
by: Han-Ying Huang, et al.
Published: (2021-05-01)

Factors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma
by: Farina M. Hanif, et al.
Published: (2014-10-01)

Low skeletal muscle mass predicts relevant clinical outcomes in head and neck squamous cell carcinoma. A meta analysis
by: Alexey Surov, et al.
Published: (2021-05-01)

Preoperative Low Muscle Mass and Low Muscle Quality Negatively Impact on Pulmonary Function in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
by: Shirai, Hisaya
Published: (2020)

Skeletal muscle mass is associated with toxicity, treatment tolerability, and additional or subsequent therapies in patients with hepatocellular carcinoma receiving sorafenib treatment
by: Koji Sawada, et al.
Published: (2019-08-01)

Factors Associated with Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
by: Taiga Otsuka, et al.
Published: (2015-05-01)

Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy.
by: Cheng-Hsiang Lo, et al.
Published: (2017-01-01)

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
by: Lee SH, et al.
Published: (2015-04-01)

Advanced Skeletal Muscle Mass Reduction (Sarcopenia) Secondary to Neuromuscular Disease
by: G. R. Pesola, et al.
Published: (2020-01-01)

Low Skeletal Muscle Mass Impairs Quality of Life in Nasopharyngeal Carcinoma Patients Treated With Concurrent Chemoradiotherapy
by: Xin Hua, et al.
Published: (2020-01-01)

VEGF overexpression predicts poor survival in hepatocellular carcinoma
by: Choi Sae Byeol, et al.
Published: (2017-12-01)

The impact of skeletal muscle mass on survival outcome in biliary tract cancer patients.
by: Panita Limpawattana, et al.
Published: (2018-01-01)

Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma
by: Qinjunjie Chen, et al.
Published: (2020-08-01)

High Expression of PIGC Predicts Unfavorable Survival in Hepatocellular Carcinoma
by: Guo X, et al.
Published: (2021-04-01)

Growth factor-dependent and independent regulation of skeletal muscle mass - Is IGF-1 necessary for skeletal muscle hypertrophy? -
by: Mitsunori Miyazaki
Published: (2013-04-01)

Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective study
by: Ja Kyung Kim, et al.
Published: (2017-08-01)

The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
by: Debora Basile, et al.
Published: (2019-04-01)

Longitudinal changes in skeletal muscle mass in patients with advanced squamous cell lung cancer
by: Jongsoo Lee, et al.
Published: (2021-06-01)

Advance in Drug Delivery for Ageing Skeletal Muscle
by: Yi Li, et al.
Published: (2020-07-01)

Serum miR-224 Reflects Stage of Hepatocellular Carcinoma and Predicts Survival
by: Li-ping Zhuang, et al.
Published: (2015-01-01)

Tailored Prediction Model of Survival after Liver Transplantation for Hepatocellular Carcinoma
by: Indah Jamtani, et al.
Published: (2021-06-01)

A genomic-clinicopathologic nomogram for predicting overall survival of hepatocellular carcinoma
by: Kena Zhou, et al.
Published: (2020-12-01)

Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival
by: Sonja M. Kessler, et al.
Published: (2019-04-01)

Sarcopenia Predicts Reduced Survival in Patients with Hepatocellular Carcinoma at First Diagnosis
by: Paola Begini, et al.
Published: (2017-01-01)

Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume
by: Kenji Imai, et al.
Published: (2017-09-01)

Development and validation of nomogram for predicting survival outcomes in patients with small hepatocellular carcinoma
by: LI Chuanhong, et al.
Published: (2020-10-01)

Low Skeletal Muscle Mass in the Lower Limbs Is Independently Associated to Knee Osteoarthritis.
by: Sang Yoon Lee, et al.
Published: (2016-01-01)

Anatomical sites (Takasaki’s segmentation) predicts the recurrence-free survival of hepatocellular carcinoma
by: Wei Qin, et al.
Published: (2021-06-01)

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
by: Younak Choi, et al.
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_ccsiqgqumcll1et7d8jn7j9ub1